Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-16-046331)

Filing Details

Accession Number:: 0001127602-16-046331
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-15 16:04:21
Reporting Period:: 2016-03-11

Filing Date:: 2016-03-15
Accepted Time:: 2016-03-15 16:04:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1472091	Edge Therapeutics Inc.	EDGE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1276550	J James Loughlin	200 Connell Drive, Suite 1600 Berkeley Heights NJ 07922		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-11	100	$7.58	100	No	4	P	Indirect	Family Trust
Common Stock	Acquisiton	2016-03-11	13	$7.63	113	No	4	P	Indirect	Family Trust
Common Stock	Acquisiton	2016-03-11	500	$7.64	613	No	4	P	Indirect	Family Trust
Common Stock	Acquisiton	2016-03-11	1,107	$7.64	1,720	No	4	P	Indirect	Family Trust
Common Stock	Acquisiton	2016-03-11	600	$7.64	2,320	No	4	P	Indirect	Family Trust
Common Stock	Acquisiton	2016-03-11	500	$7.63	2,820	No	4	P	Indirect	Family Trust
Common Stock	Acquisiton	2016-03-11	180	$7.63	3,000	No	4	P	Indirect	Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Family Trust
No	4	P	Indirect	Family Trust
No	4	P	Indirect	Family Trust
No	4	P	Indirect	Family Trust
No	4	P	Indirect	Family Trust
No	4	P	Indirect	Family Trust
No	4	P	Indirect	Family Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	19,625	Direct

Footnotes

The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.